Heterocyclic compound, hole transport composition including the same, light-emitting device including the hole transport composition, method of manufacturing the light-emitting device, and electronic apparatus including the light-emitting device

US12391699B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12391699-B2
Application numberUS-202117447685-A
CountryUS
Kind codeB2
Filing dateSep 14, 2021
Priority dateSep 18, 2020
Publication dateAug 19, 2025
Grant dateAug 19, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided are a heterocyclic compound represented by Formula 1, a hole transport composition containing the same, a light-emitting device including the hole transport composition, a method of manufacturing the light-emitting device, and an electronic apparatus including the light-emitting device, wherein each substituent in Formula 1 is the same as described in the present specification.

First claim

Opening claim text (preview).

What is claimed is: 1. A heterocyclic compound represented by Formula 1: wherein, in Formula 1, L 11 to L 13 and L 21 to L 23 are each independently a C 2 -C 20 alkenylene group unsubstituted or substituted with at least one R 10a , or a C 2 -C 20 alkynylene group unsubstituted or substituted with at least one R 10a , a11 to a13 and a21 to a23 are each independently 0, 1, 2, 3, 4, or 5, wherein at least one selected from a11 to a13 and a21 to a23 is 1, 2, 3, 4, or 5, Z 11 to Z 13 , Z 21 to Z 23 , and R 1 to R 9 are each independently hydrogen, deuterium, an azide group (—N 3 ), —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C 1 -C 60 alkyl group unsubstituted or substituted with at least one R 10a , a C 2 -C 60 alkenyl group unsubstituted or substituted with at least one R 10a , a C 2 -C 60 alkynyl group unsubstituted or substituted with at least one R 10a , a C 1 -C 60 alkoxy group unsubstituted or substituted with at least one R 10a , a C 3 -C 10 cycloalkyl group unsubstituted or substituted with at least one R 10a , a C 1 -C 10 heterocycloalkyl group unsubstituted or substituted with at least one R 10a , a C 3 -C 10 cycloalkenyl group unsubstituted or substituted with at least one R 10a , a C 1 -C 10 heterocycloalkenyl group unsubstituted or substituted with at least one R 10a , a C 6 -C 60 aryl group unsubstituted or substituted with at least one R 10a , a C 6 -C 60 aryloxy group unsubstituted or substituted with at least one R 10a , a C 6 -C 60 arylthio group unsubstituted or substituted with at least one R 10a , a C 1 -C 60 heteroaryl group unsubstituted or substituted with at least one R 10a , a C 1 -C 60 heteroaryloxy group unsubstituted or substituted with at least one R 10a , a C 1 -C 60 heteroarylthio group unsubstituted or substituted with at least one R 10a , a monovalent non-aromatic condensed polycyclic group unsubstituted or substituted with at least one R 10a , a monovalent non-aromatic condensed heteropolycyclic group unsubstituted or substituted with at least one R 10a , —Si(Q 1 )(Q 2 )(Q 3 ), —B(Q 1 )(Q 2 ), —N(Q 1 )(Q 2 ), —P(Q 1 )(Q 2 ), —C(═O)(Q 1 ), —S(═O)(Q 1 ), —S(═O) 2 (Q 1 ), —P(═O)(Q 1 )(Q 2 ), or —P(═S)(Q 1 )(Q 2 ), at least one selected from Z 11 to Z 13 , Z 21 to Z 23 , and R 1 to R 9 is —N 3 , when each of Z 11 to Z 13 is —N 3 , at least one selected from -(L 21 ) a21 -Z 21 , -(L 22 ) a22 -Z 22 , and -(L 23 ) a23 -Z 23 is hydrogen, R 10a is: deuterium (-D), —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, or a nitro group; a C 1 -C 60 alkyl group, a C 2 -C 60 alkenyl group, a C 2 -C 60 alkynyl group, or a C 1 -C 60 alkoxy group, each unsubstituted or substituted with deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, a C 3 -C 60 carbocyclic group, a C 1 -C 60 heterocyclic group, a C 6 -C 60 aryloxy group, a C 6 -C 60 arylthio group, —Si(Q 11 )(Q 12 )(Q 13 ), —N(Q 11 )(Q 12 ), —B(Q 11 )(Q 12 ), —C(═O)(Q 11 ), —S(═O) 2 (Q 11 ), —P(═O)(Q 11 )(Q 12 ), or any combination thereof; a C 3 -C 60 carbocyclic group, a C 1 -C 60 heterocyclic group, a C 6 -C 60 aryloxy group, or a C 6 -C 60 arylthio group, unsubstituted or substituted with deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, a C 1 -C 60 alkyl group, a C 2 -C 60 alkenyl group, a C 2 -C 60 alkynyl group, a C 1 -C 60 alkoxy group, a C 3 -C 60 carbocyclic group, a C 1 -C 60 heterocyclic group, a C 6 -C 60 aryloxy group, a C 6 -C 60 arylthio group, —Si(Q 21 )(Q 22 )(Q 23 ), —N(Q 21 )(Q 22 ), —B(Q 21 )(Q 22 ), —C(═O)(Q 21 ), —S(═O) 2 (Q 21 ), —P(=O)(Q 21 )(Q 22 ), or any combination thereof; or —Si(Q 31 )(Q 32 )(Q 33 ), —N(Q 31 )(Q 32 ), —B(Q 31 )(Q 32 ), —C(═O)(Q 31 ), —S(═O) 2 (Q 31 ), or —P(═O)(Q 31 )(Q 32 ), wherein Q 1 to Q 3 , Q 11 to Q 13 , Q 21 to Q 23 , and Q 31 to Q 33 are each independently: hydrogen; deuterium; —F; —Cl; —Br; —I; a hydroxyl group; a cyano group; a nitro group; a C 1 -C 60 alkyl group; a C 2 -C 60 alkenyl group; a C 2 -C 60 alkynyl group; a C 1 -C 60 alkoxy group; or a C 3 -C 60 carbocyclic group or a C 1 -C 60 heterocyclic group, each unsubstituted or substituted with deuterium, —F, a cyano group, a C 1 -C 60 alkyl group, a C 1 -C 60 alkoxy group, a phenyl group, a biphenyl group, or any combination thereof. 2. The heterocyclic compound of claim 1 , wherein Z 11 to Z 13 are each —N 3 . 3. The heterocyclic compound of claim 1 , wherein Z 21 to Z 23 are each —N 3 . 4. The heterocyclic compound of claim 1 , wherein the heterocyclic compound is represented by one selected from Formulae 2A and 2B: wherein, in Formulae 2A and 2B, L 11 to L 13 , L 21 to L 23 , Z 11 to Z 13 , Z 21 to Z 23 , and R 1 to R 9 are the same as described in claim 1 , R 11 to R 13 are each independently hydrogen, deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C 1 -C 60 alkyl group unsubstituted or substituted with at least one R 10a , a C 2 -C 60 alkenyl group unsubstituted or substituted with at least one R 10a , a C 2 -C 60 alkynyl group unsubstituted or substituted with at least one R 10a , a C 1 -C 60 alkoxy group unsubstituted or substituted with at least one R 10a , a C 3 -C 10 cycloalkyl group unsubstituted or substituted with at least one R 10a , a C 1 -C 10 heterocycloalkyl group unsubstituted or substituted with at least one R 10a , a C 3 -C 10 cycloalkenyl group unsubstituted or substituted with at least one R 10a , a C 1 -C 10 heterocycloalkenyl group unsubstituted or substituted with at least one R 10a , a C 6 -C 60 aryl group unsubstituted or substituted with at least one R 10a , a C 6 -C 60 aryloxy group unsubstituted or substituted with at least one R 10a , a C 6 -C 60 arylthio group unsubstituted or substituted with at least one R 10a , a C 1 -C 60 heteroaryl group unsubstituted or substituted with at least one R 10a , a C 1 -C 60 heteroaryloxy group unsubstituted or substituted with at least one R 10a , a C 1 -C 60 heteroarylthio group unsubstituted or substituted with at least one R 10a , a monovalent non-aromatic condensed polycyclic group unsubstituted or substituted with at least one R 10a , a monovalent non-aromatic condensed heteropolycyclic group unsubstituted or substituted with at least one R 10a , —Si(Q 1 )(Q 2 )(Q 3 ), —B(Q 1 )(Q 2 ), —N(Q 1 )(Q 2 ), —P(Q 1 )(Q 2 ), —C(═O)(Q 1 ), —S(═O)(Q 1 ), —S(═O) 2 (Q 1 ), —P(═O)(Q 1 )(Q 2 ), or —P(═S)(Q 1 )(Q 2 ), and R 10a is the same as described in claim 1 . 5. The heterocyclic compound of claim 1 , wherein R 1 to R 9 are each independently: hydrogen, deuterium, —F, —Cl, —Br, —I, a cyano group, a C 1 -C 20 alkyl group, or a C 1 -C 20 alkoxy group, a C 1 -C 20 alkyl group or a C 1 -C 20 alkoxy group, each substituted with deuterium, —F, —Cl, —Br, —I, a cyano group, a phenyl group, a biphenyl group, or any combination thereof; or a group represented by one selected from Formulae 5-1 to 5-26 and Formulae 6-1 to 6-55:

Assignees

Inventors

Classifications

  • Hole transporting layers · CPC title

  • comprising only nitrogen in the heteroaromatic polycondensed ring system, e.g. phenanthroline or carbazole · CPC title

  • C07D487/14Primary

    Ortho-condensed systems · CPC title

  • C07D487/16Primary

    Peri-condensed systems · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12391699B2 cover?
Provided are a heterocyclic compound represented by Formula 1, a hole transport composition containing the same, a light-emitting device including the hole transport composition, a method of manufacturing the light-emitting device, and an electronic apparatus including the light-emitting device, wherein each substituent in Formula 1 is the same as described in the present specification.
Who is the assignee on this patent?
Samsung Display Co Ltd
What technology area does this patent fall under?
Primary CPC classification C07D487/14. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Aug 19 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 3 related publications on this page (citations in our corpus or others sharing the same primary CPC).